A detailed history of Alpha Dna Investment Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 28,306 shares of PFE stock, worth $756,902. This represents 0.31% of its overall portfolio holdings.

Number of Shares
28,306
Previous 33,003 14.23%
Holding current value
$756,902
Previous $923,000 11.27%
% of portfolio
0.31%
Previous 0.37%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $130,106 - $147,438
-4,697 Reduced 14.23%
28,306 $819,000
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $40,971 - $48,011
-1,622 Reduced 4.68%
33,003 $923,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $148,763 - $170,828
5,746 Added 19.9%
34,625 $960,000
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $37,496 - $48,703
-1,435 Reduced 4.73%
28,879 $831,000
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $703,027 - $821,769
-21,908 Reduced 41.95%
30,314 $1.01 Million
Q2 2023

Jul 31, 2023

BUY
$36.12 - $41.79 $320,131 - $370,384
8,863 Added 20.44%
52,222 $1.92 Million
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $896,043 - $1.17 Million
22,748 Added 110.37%
43,359 $1.77 Million
Q4 2022

Jan 27, 2023

SELL
$41.75 - $54.5 $1.25 Million - $1.63 Million
-29,972 Reduced 59.25%
20,611 $0
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $2.21 Million - $2.7 Million
50,583 New
50,583 $2.21 Million
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $39,141 - $44,341
-1,090 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $12,525 - $14,125
374 Added 52.23%
1,090 $39,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $23,964 - $30,472
716 New
716 $26,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.